Serial #79115004
LIVE

Serial Number

79115004

Owner

Vela Holding Pte. Ltd

Filing Date

Nov 17, 2011

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79115004 Trademark

Serial Number: 79115004 • Registration: 4385918

Serial #79115004 is a trademark filed by Vela Holding Pte. Ltd on November 17, 2011. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Vela Holding Pte. Ltd (4 trademarks)

#02-04/05/06 The Kendall

Entity Type: 99

Vela Diagnostics Holding Ptd Ltd. (2 trademarks)

50 Science Park Road,

Entity Type: 99

Trademark Details

Filing Date

November 17, 2011

Registration Date

August 20, 2013

Published for Opposition

June 4, 2013

Cancellation Date

November 17, 2021

Goods & Services

Teaching services in the field of medical diagnosis

Scientific apparatus and instruments for laboratory use, in particular for research and development purposes in the nature of thermocyclers for amplifying, and analyzing biopolymers, in particular nucleic acids and biologically active substances; scientific apparatus and instruments for scientific research, non-medical diagnostic analysis, chemical analysis, clinical analysis, namely, electrophoretic apparatuses, homogenizers for marking, separating, isolating, purifying, amplifying, and analyzing biopolymers, in particular nucleic acids, proteins macromolecules and biologically active substances, spectrophotometers for measuring relative DNA; RNA and protein; computer hardware; computer software for operation and maintenance of scientific apparatus, instruments and equipment, namely, for electrophoretic apparatuses, homogenizers, spectrophotometers and laboratory robots; computer software for creating experimental profiles and providing experimental reports based on sample preparation, modification and manipulation of cells as well as on synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules; computer software for creating reports of apparatus performance verification; computer software for analyzing, displaying and visualizing experimental data and biological data, namely, PCR data, Real-Time-PCR data, and electrophoresis data

Pharmaceutical and veterinary preparations, namely, biological substances and chemicals used for medical diagnostic purposes, namely, reagents and solvents, in particular for sample preparation, modification and manipulation of cells as well as for the performance of a synthesis, amplification, labeling, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances; kits consisting primarily of protein assays and chemical reagents for medical scientific and medical research purposes, in particular for sample preparation, modification and manipulation of cells as well as for synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules; in-vitro diagnostic preparations for medical purposes; sanitary preparations for medical purposes

Data processing services

Biological and chemical substances used in industry and for scientific and research purposes, namely, diagnostic preparations, except for human medicine and veterinary medicine purposes; reagents and solvents for research and not for human medical and veterinary purposes, in particular for sample preparation, modification and manipulation of cells as well as for the performance of labeling, synthesis, amplification, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances; kits consisting primarily of nucleic acid assays and chemical reagents for research, except for human medicine and veterinary medicine purposes, in particular for sample preparation, modification and manipulation of cells as well as for synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules

Medical consultations; consulting services in the field of health; medical services; health care services; medical clinics; medical care services

Medical apparatus and implements, namely, apparatus and implements for the conducting and evaluation of clinical diagnostic examinations for medical purposes

Scientific and technological services and research services and scientific consultancy services in the field of scientific research, analysis and testing in the field of clinical, veterinary, environmental and medical diagnosis; development of computer hardware and software for the operation and maintenance of scientific apparatus, instruments and equipment; development of computer software for creating experimental profiles, providing experimental reports and reports of apparatus performance verification; development of computer software for analyzing, displaying and visualizing experimental data and biological data

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jun 11, 2022 DENC
DEATH OF INTERNATIONAL REGISTRATION
Jun 11, 2022 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Jan 22, 2022 INNT
GENERIC MADRID TRANSACTION SENT TO IB
Dec 23, 2021 XXSS
GENERIC MADRID TRANSACTION CREATED
Dec 23, 2021 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 26, 2021 INTR
NEW REPRESENTATIVE AT IB RECEIVED
Aug 27, 2021 NREP
CANCELLED SECTION 71
Feb 26, 2021 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 20, 2018 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Feb 12, 2016 NREP
CHANGE OF OWNER RECEIVED FROM IB
Feb 12, 2016 CHLD
NEW REPRESENTATIVE AT IB RECEIVED
Feb 13, 2015 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 14, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 22, 2013 FICS
FINAL DISPOSITION PROCESSED
Nov 22, 2013 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 20, 2013 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 20, 2013 R.PR
NOTIFICATION PROCESSED BY IB
Jul 21, 2013 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 4, 2013 NPUB
PUBLISHED FOR OPPOSITION
Jun 4, 2013 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 15, 2013 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 15, 2013 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 15, 2013 NONP
WITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 28, 2013 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 16, 2013 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 16, 2013 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 16, 2013 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 16, 2013 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 16, 2013 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 16, 2013 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 8, 2013 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Mar 17, 2013 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 7, 2013 PREV
ASSIGNED TO LIE
Mar 7, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 25, 2013 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 11, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 6, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 6, 2013 TROA
REFUSAL PROCESSED BY IB
Aug 30, 2012 RFNT
APPLICATION FILING RECEIPT MAILED
Aug 11, 2012 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 9, 2012 RFCS
REFUSAL PROCESSED BY MPU
Aug 9, 2012 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 9, 2012 RFCR
NON-FINAL ACTION WRITTEN
Aug 8, 2012 CNRT
ASSIGNED TO EXAMINER
Aug 7, 2012 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 7, 2012 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 6, 2012 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 2, 2012 REPR